D.C. Mun. Regs. tit. 22, r. 22-C6410

Current through Register Vol. 71, No. 52, December 27, 2024

Rule 22-C6410 - RESULT REPORTING

6410.1

A testing laboratory shall issue results for each sample tested which shall address the following:

(a) Whether the chemical profile of the medical marijuana sample conforms to the accepted variety for the following compounds:

(1) Delta-9-tetrahydrocannabinol (THC);

(2) Delta-9-tetrahydrocannabinolic acid (THCA);

(3) Cannabidiol (CBD);

(4) Cannabidiolic acid (CBDA);

(5) The terpenes described in the most current version of the cannabis inflorescence monograph published by the American Herbal Pharmacopeia (AHP);

(6) Cannabigerol (CBG); and

(7) Cannabinol (CBN);

(b) That the presence of the following contaminants do not exceed the levels as provided in §§6409 of this subtitle;

(1) Heavy metals; and

(2) Pesticide residue;

(c) The presence of microbial impurities, including but not limited to:

(1) The total aerobic microbial count (TAMC);

(2) The total combined yeast and molds count (TYMC);

(3) Pseudomonas aeruginosa (P. aeruginosa);

(4) Aspergillus spp;

(5) Staphylococcus aureus (S. aureus);

(6) Aflatoxin B₁, B₂, G₁ and G₂; and

(7) Ochratoxin A;

(d) Whether the batch is within specification for the characteristics of:

(1) Odor;

(2) Appearance;

(3) Fineness; and

(4) Moisture content.

6410.2

The testing laboratory shall enter results into the Board's electronic tracking system within twenty-four (24) hours from the date of the test.

6410.3

The level of contaminants in medical marijuana and medical marijuana products shall not exceed the standards provided in this subtitle, and if any of the standards are exceeded, the cultivation center shall not sell or otherwise transfer any portion of the batch of medical marijuana or medical marijuana products to a dispensary.

6410.4

In the event the testing laboratory results determine that the sample does not meet the standards required in this subtitle, the cultivation center may seek approval from the Board to reprocess the batch and/or harvest. If written approval is granted by the Board, the cultivation center may:

(a) Reprocess the batch and/or harvest according to their SOPs; and

(b) Have the reprocessed product tested by the same testing laboratory.

6410.5

Upon receiving notification in the tracking system that the batch failed to pass testing, a cultivation center shall immediately quarantine the non-conforming batch until any reprocessing and testing is performed; or until the batch is destroyed by MPD.

6410.6

For purposes of this section, quarantine means that the batch shall be separated from all other inventory and the quarantine status shall be indicated in the tracking system. The quarantine shall be lifted only by the Board in writing, and only upon receipt of test results in the inventory tracking system documenting that the batch conforms to the required testing standards.

6410.7

The testing laboratory shall notify the Board of results that do not meet the standards and specifications set forth in this subtitle within twenty-four (24) hours of completion of analysis.

6410.8

A cultivation center shall release a batch and/or harvest for sale only if the results from the laboratory testing facility have determined that the sample has met the standards and specifications set forth in this subtitle.

D.C. Mun. Regs. tit. 22, r. 22-C6410

Final Rulemaking published at 65 DCR 10217 (8/9/2019); amended by Final Rulemaking published at 71 DCR 2388 (3/8/2024)